Dashboard
Manage Tickers

GHRS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

depression-focused-gh-research-shares-could-see-significant-upside-analyst
Depression-Focused GH Research Shares Coul...
10/13/2025 18:07:06

GH Research's GH001 shows strong Phase 2 results for treatment-resistant depression, with FDA issues nearly resolved and $1...

this-monopar-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This Monopar Therapeutics Analyst Begins C...
10/13/2025 12:25:51

needham-initiates-coverage-on-gh-research-with-buy-rating-announces-price-target-of-19
Needham Initiates Coverage On GH Research ...
10/13/2025 10:11:06

Needham analyst Ami Fadia initiates coverage on GH Research (NASDAQ:GHRS) with a Buy rating and announces Price Target of $19.

gh-research-to-present-long-term-data-on-depression-treatment-at-38th-european-neuropsychopharmacology-congress
GH Research to Present Long-Term Data on D...
10/09/2025 11:14:26

GH Research PLC (NASDAQ:GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by de...

gh-research-q2-eps-015-beats-021-estimate
GH Research Q2 EPS $(0.15) Beats $(0.21) E...
08/07/2025 11:15:12

GH Research (NASDAQ:GHRS) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.21) b...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 17:06:04

gh-research-reports-73-remission-at-6-months-in-trd-trial-fda-engagement-on-gh001-ind-ongoing-global-pivotal-launch-set-for-2026
GH Research Reports 73% Remission At 6 Mon...
07/23/2025 12:14:11

Engagement with FDA on GH001 IND complete response ongoingThe fully completed Open-Label Extension analysis confirms a 73% remi...

Core News & Articles
'House Votes To Let VA Doctors Recommend M...
06/25/2025 17:42:29

https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-mari

Core News & Articles
"RFK Says Trump Administration Could Provi...
06/24/2025 17:44:06

https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-military-veterans-within-12-...

jmp-securities-reiterates-market-outperform-on-gh-research-maintains-39-price-target
JMP Securities Reiterates Market Outperfor...
06/24/2025 13:41:57

JMP Securities analyst Jason Butler reiterates GH Research (NASDAQ:GHRS) with a Market Outperform and maintains $39 price ta...

Core News & Articles
'Psychedelics Proponents Hope Trump Admini...
06/18/2025 14:23:44

https://www.statnews.com/2025/06/18/fda-approval-psychedelics-rfk-jr-trump-allies-see-opening-mdma-psilocybin-mental-health-tre...

Core News & Articles
Reported June 17, 2025: 'Alaska Activists ...
06/18/2025 14:22:32

https://www.marijuanamoment.net/alaska-activists-launch-campaign-to-put-psychedelics-legalization-measure-on-2026-ballot/

guggenheim-maintains-buy-on-gh-research-lowers-price-target-to-29
Guggenheim Maintains Buy on GH Research, L...
05/09/2025 16:37:52

Guggenheim analyst Yatin Suneja maintains GH Research (NASDAQ:GHRS) with a Buy and lowers the price target from $32 to $29.

hc-wainwright--co-reiterates-buy-on-gh-research-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on GH R...
05/09/2025 13:34:43

HC Wainwright & Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $40 price tar...

gh-research-q1-eps-019-beats-039-estimate
GH Research Q1 EPS $(0.19) Beats $(0.39) E...
05/08/2025 11:30:50

GH Research (NASDAQ:GHRS) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.39) b...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 12:09:53

correction-guggenheim-initiated-coverage-on-the-stock-with-a-buy-rating-and-announced-a-32-price-target-on-march-13
CORRECTION: Guggenheim initiated coverage ...
03/19/2025 19:56:30

guggenheim-initiates-coverage-on-gh-research-with-buy-rating-announces-price-target-of-32
Guggenheim Initiates Coverage On GH Resear...
03/13/2025 15:25:41

Guggenheim analyst Eddie Hickman initiates coverage on GH Research (NASDAQ:GHRS) with a Buy rating and announces Price Targe...

rbc-capital-initiates-coverage-on-gh-research-with-outperform-rating-announces-price-target-of-31
RBC Capital Initiates Coverage On GH Resea...
03/07/2025 16:31:22

RBC Capital analyst Brian Abrahams initiates coverage on GH Research (NASDAQ:GHRS) with a Outperform rating and announces Pr...

stifel-maintains-buy-on-gh-research-raises-price-target-to-32
Stifel Maintains Buy on GH Research, Raise...
02/27/2025 15:30:22

Stifel analyst Paul Matteis maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $18 to $32.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION